Funding awarded
- Clinical and Translational Science Center - TL1 awarded by National Center for Advancing Translational Sciences Key Personnel 2022 - 2027
- Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target Engagement awarded by National Institute of Neurological Disorders & Stroke Key Personnel 2020 - 2026
- Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction awarded by National Institute on Aging Key Personnel 2024 - 2025